Veza, the identity security company, today announced the launch of Veza for Oracle Applications, a new offering to unify and secure access governance across complex Oracle environments, including ...

Introduction The past decade has witnessed significant advancements in genome-targeted oncology drugs within the realm of precision medicine (PM). However, the cost-effectiveness of oncology PM in a ...

Background The elimination of HBV covalently closed circular DNA (cccDNA) remains a critical hurdle for chronic hepatitis B (CHB) management. Objective In this investigation, we examined the efficacy ...